UNSPSC 51351905: Mestranol

This classification denotes a therapeutic estradiol with the molecular formula C21H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B2V233XGE7, chemically known as 19-norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17.alpha.)- but generally known as mestranol, which bears US NIH Compound Identifier 4080. European Medicines Agency schedules Mestranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08791MIG.

UNSPSC 51351905 Mestranol, a Commodity code, addresses the procurement of mestranol, a synthetic estrogen used in combination oral contraceptive formulations. State and local governments procure mestranol primarily through public health departments, Medicaid programs, family planning clinics, and correctional health services to support reproductive health and disease prevention initiatives. The drug is supplied as finished pharmaceutical products — typically tablet formulations in standard dosages — rather than as raw chemical ingredients, and purchases reflect routine inventory replenishment for ongoing clinical operations and patient dispensing.

The source provided contains no recent state or local contract opportunities tagged to this code. Without visibility into active solicitations, issuing-body participation patterns, or geographic concentration, no meaningful characterization of current market activity, repeat buyers, or regional procurement focus can be established from available data.